These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31771971)

  • 21. Carrier screening for thalassemia and hemoglobinopathies in Canada.
    Langlois S; Ford JC; Chitayat D; ;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):950-959. PubMed ID: 19038079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carrier screening and prenatal diagnosis of hemoglobinopathies. A study of indigenous and immigrant couples in northern Greece, over the last 5 years.
    Theodoridou S; Alemayehou M; Prappas N; Karakasidou O; Aletra V; Plata E; Tsaftaridis P; Karababa P; Boussiou M; Sinopoulou K; Hatzi A; Voskaridou E; Loutradi A; Manitsa A
    Hemoglobin; 2008; 32(5):434-9. PubMed ID: 18932067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haemoglobinopathies in Greece: prevention programme over the past 35 years.
    Loukopoulos D
    Indian J Med Res; 2011 Oct; 134(4):572-6. PubMed ID: 22089622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prenatal diagnosis of thalassemia and of the sickle cell syndromes in Greece.
    Loukopoulos D; Hadji A; Papadakis M; Karababa P; Sinopoulou K; Boussiou M; Kollia P; Xenakis M; Antsaklis A; Mesoghitis S
    Ann N Y Acad Sci; 1990; 612():226-36. PubMed ID: 2291550
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of the validity of Hb A2 and mean corpuscular haemoglobin action values in antenatal screening for beta thalassaemia carriers in England.
    Daniel Y; Cartwright R; Rennie K; Streetly A; Howard J
    Br J Haematol; 2014 Aug; 166(4):607-11. PubMed ID: 24754789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementation of universal newborn bloodspot screening for sickle cell disease and other clinically significant haemoglobinopathies in England: screening results for 2005-7.
    Streetly A; Latinovic R; Hall K; Henthorn J
    J Clin Pathol; 2009 Jan; 62(1):26-30. PubMed ID: 19103854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thalassemia and sickle-cell disease in Norway].
    Graesdal JS; Gundersen K; Holm B; Waage A
    Tidsskr Nor Laegeforen; 2001 Feb; 121(6):678-80. PubMed ID: 11293347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sickle cell and thalassaemia: screening for all.
    Anglin S
    Pract Midwife; 2007 Apr; 10(4):22-4. PubMed ID: 17476893
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevention and control of thalassemia at Saraburi Regional Hospital.
    Chareonkul P; Kraisin J
    J Med Assoc Thai; 2004 Jan; 87(1):8-15. PubMed ID: 14971529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening of antenatal patients in a multiethnic community for beta thalassaemia trait.
    Bain BJ
    J Clin Pathol; 1988 May; 41(5):481-5. PubMed ID: 3384979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of newborn sickle cell screening programme in England: 2010-2016.
    Streetly A; Sisodia R; Dick M; Latinovic R; Hounsell K; Dormandy E
    Arch Dis Child; 2018 Jul; 103(7):648-653. PubMed ID: 29104181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethnicity questions and antenatal screening for sickle cell/thalassaemia [EQUANS] in England: a randomised controlled trial of two questionnaires.
    Dyson SM; Culley L; Gill C; Hubbard S; Kennefick A; Morris P; Rees D; Sutton F; Squire P
    Ethn Health; 2006 May; 11(2):169-89. PubMed ID: 16595318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Client views and attitudes to non-invasive prenatal diagnosis for sickle cell disease, thalassaemia and cystic fibrosis.
    Hill M; Compton C; Karunaratna M; Lewis C; Chitty L
    J Genet Couns; 2014 Dec; 23(6):1012-21. PubMed ID: 24788196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a measure of informed choice suitable for use in low literacy populations.
    Dormandy E; Tsui EY; Marteau TM
    Patient Educ Couns; 2007 Jun; 66(3):278-95. PubMed ID: 17300913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatal diagnosis of hemoglobinopathies in Tunisia: an 18 years of experience.
    Ouali F; Siala H; Bibi A; Hadj Fredj S; Dakhlaoui B; Othmani R; Ouenniche F; Zouari F; Bouguerra B; Rezigua H; Fattoum S; Messaoud T
    Int J Lab Hematol; 2016 Jun; 38(3):223-32. PubMed ID: 26993054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood spot screening. Interview by Dina Leifer.
    Anionwu E
    Nurs Stand; 2004 Nov 3-9; 19(8):16-7. PubMed ID: 15552462
    [No Abstract]   [Full Text] [Related]  

  • 37. Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.
    Hussein N; Weng SF; Kai J; Kleijnen J; Qureshi N
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD010849. PubMed ID: 26264938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thalassaemia screening in pregnancy.
    Leung TN; Lau TK; Chung TKh
    Curr Opin Obstet Gynecol; 2005 Apr; 17(2):129-34. PubMed ID: 15758603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reliability of the current newborn screening action value for beta thalassaemia disease detection in England: A prospective study.
    Daniel Y; Henthorn J
    J Med Screen; 2019 Jun; 26(2):67-70. PubMed ID: 30249157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obstetric aspects of midtrimester fetal blood sampling by needling or fetoscopy.
    Fairweather DV; Ward RH; Modell B
    Br J Obstet Gynaecol; 1980 Feb; 87(2):87-99. PubMed ID: 7362808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.